Define the treatment objective and wastewater envelope
Coagulant dosing system design criteria should be based on treatment objectives, wastewater variability, verified jar-test results, chemical properties, required dose range and available flow and control signals—not flow rate alone. The skid must deliver accurate chemical mass dosage across the design flow envelope while controlling pH and providing monitoring, alarms and verification. Multivariable influent data provide a stronger basis for control than a simple flow-and-effluent-turbidity relationship. A practical design then confirms pump and tank duty, compatibility, containment, controls and commissioning acceptance criteria.
Start with the pollutant and required treatment result. Coagulation may support suspended-solids removal, phosphorus or color reduction, oil and grease capture, metals removal or organic-matter control; these objectives do not imply one universal chemical or skid arrangement. If the downstream operation is clarification or flotation, the comparison between DAF versus clarifier selection for chemical wastewater should be coordinated with the dosing duty, because mixing and solids separation affect the selected operating window.
Document the wastewater envelope rather than describing it as “variable.” Include flow, pH, temperature, suspended solids, turbidity, oil and grease, metals, color, organic load, salinity and constituents relevant to the proposed coagulant. Record production, cleaning, discharge and seasonal effects. Ratnaweera, Blom and Aasgaard, in their 1994 Springer Berlin Heidelberg paper, state that influent-quality fluctuations during a day, week or season can be significant and complicate coagulant control.
Use representative samples, not only a clean-water grab sample. Jar testing should establish the coagulant dose-response curve, acceptable pH condition, floc quality and settling or flotation response. The dose that meets the treatment objective in the laboratory becomes a design input only after the team defines how it will change with flow and wastewater composition. For a broader treatment context, review MBBR design guidance for food-processing wastewater when biological treatment precedes or follows coagulation.
Finally, define treated-water limits and the operating availability required. Continuous production flow, batch discharges and peak events need different turndown and reserve assumptions. Separate the normal operating envelope from the conservative design duty, and document what happens when demand exceeds the validated dose range.
| Design input | Evidence a buyer must obtain | Design consequence |
|---|---|---|
| Treatment objective | Target pollutant, final quality limit and downstream process requirements | Coagulant shortlist, jar-test endpoints and required monitoring |
| Wastewater envelope | Flow, pH, temperature, solids, turbidity, oil and grease, metals, color, organics and salinity as applicable | Maximum duty, control signals and operating limits |
| Variability | Production, shift, batch, discharge and seasonal sampling records | Turndown, storage reserve and control architecture |
| Availability | Continuous or batch operation, maintenance access and treatment interruption consequences | Duty/standby scope and fail-safe behavior |
Establish the chemical and dosing basis
The selected product must match both the treatment chemistry and the physical equipment envelope. A chemical that performs well in a jar test can still produce an unsafe or inaccurate skid if its concentration, viscosity, temperature behavior or material compatibility is not documented.
Shortlist coagulants against the target pollutant, wastewater constituents, required pH condition and downstream effects. Do not select solely by unit cost. Use representative samples and candidate pH conditions to determine the coagulant dose-response curve, floc formation, settling or flotation performance and acceptable operating range. This is consistent with the multi-criteria coagulant-selection approach described by Desalination in its paper on chemically assisted primary sedimentation.
Hydrochemix’s August 2026 guide gives general reference values of 50–300 mg/L for PAC, 30–200 mg/L for PFS and 0.5–5 mg/L for PAM, with corresponding pH ranges of 5.5–8.0, 4.5–8.0 and 6.0–9.0. These are general guide values, not universal design values, and the source identifies PAM as a flocculation aid rather than a coagulant substitute. The 2025 Scientific Reports drilling-wastewater study further explains that coagulation performance depends on colloidal surface charges, pH, organic matter and wastewater characteristics.
Before releasing an RFQ, require the supplier to confirm active concentration, density, viscosity, temperature limits, storage requirements and compatibility with tanks, hoses, pipes, seals and pump materials. A pump calibrated for a low-viscosity product may not meter a viscous polymer correctly; a polymer make-down system may require a separate duty and control signal from the coagulant system. The PLC-controlled automatic chemical dosing skid should therefore be offered against a defined chemical schedule, not merely a chemical name.
- Define the treatment endpoint and candidate coagulants.
- Jar-test each candidate product across representative wastewater and pH conditions.
- Select the chemical and establish the validated dose and pH window.
- Obtain physical-property and compatibility data before specifying equipment.
- Separate coagulant and flocculant duties where separate products are used.
| Chemical | General guide range from Hydrochemix, August 2026 | General guide pH range | Design treatment |
|---|---|---|---|
| PAC | 50–300 mg/L | 5.5–8.0 | Confirm by jar test for the actual wastewater |
| PFS | 30–200 mg/L | 4.5–8.0 | Confirm product properties, dose and pH window |
| PAM | 0.5–5 mg/L | 6.0–9.0 | Treat as a flocculation aid with a separate duty where applicable |
Any general chemical range should be checked against the project’s jar-test record, the selected product data sheet and the supplier’s chemical compatibility evidence.
Calculate flow and chemical delivery duty
Pump and tank sizing must follow from the verified mass-demand calculation, not from average wastewater flow. The governing point is the combination of maximum expected flow, maximum validated dose and maximum expected stock concentration.
Define the required chemical mass rate as:
Chemical mass rate (kg/h) = wastewater flow (m³/h) × dose (mg/L) ÷ 1,000,000 × chemical active fraction.
If the stock is dosed as a prepared solution, convert the active mass rate to solution mass and then volumetric feed:
Solution feed rate (m³/h) = active chemical mass rate (kg/h) ÷ solution concentration (kg/m³).
The wastewater flow must be expressed in m³/h and the dose in mg/L. The active fraction and solution concentration must come from the selected product. For a daily requirement, multiply the mass rate by the operating hours in the relevant delivery period.
Select the metering-pump duty at the maximum expected wastewater flow, highest validated dose and maximum design concentration. Establish minimum and maximum operating points from the approved operating envelope, then check whether the metering pump can deliver that range with acceptable accuracy and adequate turndown. If stock concentration changes, the physical volume required changes even when the target mg/L dose remains constant.
Set out the procedure for demand above the validated range. Options include an operator-confirmed setpoint increase, a defined maximum-dose alarm, or stopping an upstream batch discharge. The design should not imply that unlimited flow or dose can be accommodated.
Determine tank working volume, usable reserve and transfer method from the supplier-verified chemical density and the plant’s maximum delivery interval. Do not accept an unexplained volume multiplier. Specify whether the vessel contains neat chemical or prepared polymer, and whether agitation is prohibited by the product supplier. A gravity-fed or eductor arrangement may be suitable only after checking pressure, viscosity, pulsation and accuracy; a positive-displacement metering pump is generally the appropriate reference for controlled chemical feed, but the final selection follows from the chemical and site constraints. The water-treatment valves and media scope should identify compatible metering and isolation components rather than leaving them generic.
| Duty calculation | Required input | Output for RFQ |
|---|---|---|
| Mass demand | Maximum flow, validated dose, active fraction | Maximum and normal kg/h |
| Volumetric feed | Mass demand and stock concentration | Maximum and normal L/h |
| Pump turndown | Minimum and maximum validated operating points | Minimum flow, maximum flow and metering accuracy |
| Storage | Supplier-verified density and maximum delivery interval | Working volume, usable reserve and transfer method |
| Over-range demand | Approved process limit and operator response | Alarm, interlock or batch-control action |
Select a control architecture that reflects process delay
A simple flow-paced system is understandable, but it does not necessarily control treatment demand when wastewater quality changes independently of flow.
Ratnaweera, Blom and Aasgaard reported a correlation coefficient of 0.58 for Dosage = f (flow, effluent turbidity), while models with comprehensive influent descriptions produced coefficients above 0.90. The simple strategy is attractive because flow is commonly measured, while relevant influent parameters such as turbidity and phosphates are less often monitored. However, the result shows that an easily implemented relationship should not be treated as equivalent to a multivariable control model.
The process delay matters. Ratnaweera and colleagues report sedimentation times of 2–6 hours, making immediate feedback from effluent turbidity impossible. A control system based on delayed effluent feedback must therefore avoid assuming that a setpoint change will produce an immediate measured response. Upstream signals, verified operating data and operator-confirmed limits are more defensible for near-term corrections.
Use a staged architecture:
- Baseline: wastewater flow-paced dosing provides the predictable mass feed required for each operating state.
- Trim: add pH or conductivity feedback where the process objective and measurement response justify it.
- Multivariable adjustment: introduce feedforward or model-based setpoint adjustment only when the required influent measurements, calibration, signal quality and operating history are available.
The comparison in wastewater dosing system PLC and SCADA architecture should be used to define signals, modes and alarms rather than assuming continuous automatic adjustment is always appropriate.
Artificial neural networks, extreme learning machines and random forest methods are optimization options, not default control methods. The 2025 Scientific Reports drilling-wastewater study describes ANN, ELM and RF as data-driven alternatives where detailed mechanistic inputs are impractical, while noting that jar tests are time-consuming and atypical wastewater conditions can invalidate fixed settings.
| Control architecture | Evidence reported by Ratnaweera et al., 1994 | Principal limitation | Appropriate use |
|---|---|---|---|
| Flow plus effluent turbidity | Correlation coefficient of 0.58 | Delayed effluent response and incomplete influent description | Initial or fallback control where additional monitoring is unavailable |
| Multivariable empirical model | Correlation coefficients above 0.90 for models with comprehensive influent descriptions | Requires instrumentation, calibration and representative operating data | Validated automatic setpoint adjustment |
| Data-driven ANN, ELM or RF | Described as alternatives for nonlinear, data-limited systems in the 2025 Scientific Reports study | Requires adequate historical and operating data | Optimization after operating history and validation are available |
For implementation detail, align signal quality, alarm behavior and failure states with wastewater automation controls for treatment reliability.
Specify the skid, instrumentation and safety systems
The RFQ must specify functional proof of chemical delivery, not just a skid outline or PLC enclosure. Require a documented operating envelope, material schedule, electrical arrangement and test method.
Specify PLC-controlled automatic chemical dosing with a human-machine interface, dose setpoint control, operating-status indication, alarm history, event logging and access control. Define the measurement chain: wastewater flow, chemical flow or mass indication, tank level, relevant pH and process-quality signals. For each signal, state the instrument range, accuracy, calibration method, signal-quality checks, failure state and effect on the control loop.
Build an approved cause-and-effect matrix covering high and low tank level, pump fault, high and low flow, excessive chemical consumption, power failure and out-of-range process conditions. The final alarm set should reflect the actual plant arrangement rather than adding every listed function indiscriminately.
Require secondary containment, bunding, safe chemical storage, appropriate venting or pressure management, safe access, labelled valves and compatible wetted parts. The containment arrangement must be checked against the selected chemical and site conditions. Address electrical classification, grounding, cable routing and enclosure protection only after a site-specific hazard review; the supplied research does not establish a universal hazardous-area classification.
Include duty/standby decisions, manual operating mode, calibration vessels, flushing provisions and maintenance isolation points. Specify what happens when the duty pump fails, a level instrument becomes unreliable, power is lost or a chemical delivery signal departs from its approved range. The industrial DAF separation system interface should be identified where the skid feeds a flotation unit so chemical delivery, mixing and solids handling can be commissioned as a coordinated process.
HydropureWater’s automatic chemical dosing system is directly relevant because it is described as PLC-controlled, skid-mounted, pre-wired and factory-tested for coagulants, flocculants, pH adjusters and specialty chemicals. That description is a product configuration fact, not evidence that a proposed duty or metering accuracy has already been met.
| RFQ area | Minimum information required | Supplier response |
|---|---|---|
| Chemical contact | Product, concentration, density, viscosity and compatibility data | Material schedule and exceptions |
| Delivery | Duty range, turndown, metering accuracy and calibration method | Guaranteed duty points |
| Controls | I/O list, control modes, cause-and-effect matrix and signal failure states | PLC/HMI narrative and drawings |
| Storage and safety | Working volume, reserve, containment, venting, access and isolation | Layout and safety provisions |
| Electrical | Supply, power loss, UPS or battery requirement, classification basis and cabling | Electrical schedule and drawings |
| Maintainability | Duty/standby, manual mode, flush points and calibration vessels | Operating and maintenance procedure |
Validate the design through commissioning and operating tests
Commissioning should demonstrate that the delivered skid delivers the calculated chemical mass dose and behaves as the approved cause-and-effect matrix requires.
Create a factory or site acceptance-test matrix covering low, normal and high flow; low, normal and high concentration; setpoint changes; tank-level changes; power loss and instrument-failure recovery. Where the supplier cannot reproduce every process condition, the test method and extrapolation basis must be documented rather than left implicit.
Verify actual chemical delivery against the approved calculation and the manufacturer’s stated metering accuracy. Test records should identify instrument ranges, calibration conditions, test fluid or chemical, actual flow or mass delivered and calculation method. Confirm alarms, interlocks, manual fallback, level tracking, flow scaling, chemical-use records and PLC logic against the approved cause-and-effect matrix.
Run a coordinated water test before the full chemical trial. This can expose leaks, blocked lines, air entrainment, reverse flow, poor access and incorrect cable or instrument connections without introducing unnecessary chemical risk. Then conduct the chemical trial under controlled conditions and compare process response with the jar-test basis.
Establish a jar-test-to-full-scale review plan. The 2025 Scientific Reports study notes that time-consuming jar tests and atypical raw-water conditions can leave fixed settings inadequate. A review trigger can include a wastewater composition change, chemical-product substitution, sustained process-quality deterioration or a verified change in flow and influent behavior.
Final handover should include operating procedures, calibration records, as-built drawings, chemical data sheets, cause-and-effect matrices, test certificates, spare parts and a documented method for updating validated dose limits. Treat the operating-envelope record as controlled design information, not an informal note left with the operator.
| Test | Acceptance evidence | Record retained |
|---|---|---|
| Low, normal and high duty | Delivered mass agrees with the approved calculation within the stated metering accuracy | Calibration and duty-test record |
| Setpoint and flow scaling | PLC output, pump response and calculated dose agree with the control narrative | Trend, test script and deviations |
| Failure tests | Alarms, interlocks, fallback mode and recovery match the cause-and-effect matrix | Witnessed test certificate |
| Water test | No leaks, blockage, air entrainment or reverse flow; access and connections are satisfactory | Punch-list and rectification record |
| Chemical trial | Process response is reviewed against the jar-test and operating-envelope basis | Trial report and approved dose limits |
Build a vendor-ready design and procurement checklist
A comparable RFQ must state the same design basis for every supplier. Ask each bidder to identify the design wastewater flow, validated chemical dose range, maximum expected concentration, duty point, turndown, metering accuracy, control signal, alarms and test method. The completed calculation—not a sales duty table—should define the required delivery rate.
- Attach the wastewater envelope, jar-test results and treated-water objectives.
- Provide the selected product data and material-compatibility requirements.
- Include the mass-demand calculation, storage basis and operating points.
- Specify the PLC, HMI, I/O, alarms, failure states and electrical requirements.
- Attach the acceptance-test matrix and required handover records.
Request chemical-compatibility evidence, PLC and HMI documentation, material schedules, electrical drawings, battery or UPS requirements, calibration procedures and commissioning scope. Separate the quoted equipment from site utilities, civil works, chemical supply, installation, training, commissioning and long-term spare parts.
Make the acceptance test and operating-envelope documentation contractual. An enclosure rating or PLC capability alone does not prove accurate chemical dosing. Compare suppliers by verified delivery performance, chemical compatibility, control behavior, safety provisions and completeness of the acceptance evidence.
The supplied research does not provide a defensible universal skid-price range. Request a project-specific quotation against the completed design basis rather than comparing an unsupported generic price.
| RFQ package | Buyer action | Supplier response to compare |
|---|---|---|
| Design basis | Issue the same flow, dose, concentration, chemical and quality requirements | Guaranteed operating envelope |
| Technical scope | Require equipment, utilities, civil, installation and training boundaries | Explicit exclusions and deliverables |
| Compliance evidence | Request compatibility, electrical and safety documentation | Complete schedules and drawings |
| Acceptance | Define measurable test cases and handover records | Contractual compliance without unexplained exceptions |
| Commercial comparison | Use the completed scope as the quotation basis | Project-specific lump sum or schedule of rates |
Frequently Asked Questions
How much should I budget for an automatic coagulant dosing system?
Do not use a universal price for budgeting. The supplied evidence does not provide a defensible equipment-cost range for a coagulant dosing skid, and Hydrochemix’s August 2026 treatment costs are not skid quotations. Request a project-specific price using the completed design basis: wastewater flow, validated dose range, stock concentration, metering duty, pump redundancy, storage, containment, electrical scope, controls, installation and commissioning.
What flow rate and dose range should I state in a supplier RFQ?
State the maximum expected wastewater flow, normal operating flow, minimum validated dose, maximum validated dose, maximum expected stock concentration and maximum permitted delivery interval. Support the values with representative jar-test results and the chemical mass-demand calculation. Do not substitute a general PAC, PFS or PAM guide range for project-specific validation.
Is flow-paced dosing adequate for variable industrial wastewater?
Flow-paced dosing can provide a stable baseline, but it does not account for quality changes that occur independently of flow. In Ratnaweera, Blom and Aasgaard’s 1994 paper, flow-plus-effluent-turbidity dosing produced a correlation coefficient of 0.58, compared with coefficients above 0.90 for models with comprehensive influent descriptions. Use a stronger strategy only when the required measurements, calibration and operating data can support it.
How do I compare automatic chemical dosing system suppliers?
Compare suppliers on guaranteed duty range, turndown, metering accuracy, chemical compatibility, control logic, alarm behavior, failure states, containment, documentation and witnessed acceptance testing. Require each bidder to state how the proposed system will pass the same low-, normal- and high-duty test matrix. A PLC and skid enclosure are not sufficient evidence of metering performance.
What operating data should I collect before selecting a control strategy?
Collect synchronized wastewater flow, pH, temperature, turbidity, relevant chemical constituents, chemical-flow or mass records, tank levels and treated-water quality. Include jar-test results, chemical usage, operator setpoint changes and wastewater-production events. Retain the operating periods that represent normal, peak and atypical conditions, because the 1994 study found that influent quality can fluctuate significantly within a day, week or season.
